Induction of Periodontitis via a Combination of Ligature and Lipopolysaccharide Injection in a Rat Model
February 17th, 2023
In this study, a rat model of induction of periodontitis is presented via a combination of retentive ligature and repetitive injections of lipopolysaccharide derived from Porphyromonas gingivalis, over 14 days around the first maxillary molars. The ligation and LPS injection techniques were effective in inducing peridontitis, resulting in alveolar bone loss and inflammation.
This is a rat model of experimental periodontitis, based on the techniques of lipopolysaccharide injections combined with ligature placement, offering an effective method to study disease progression and to evaluate treatments for periodontitis. Combining both techniques with individual methods culminates in a rapid disease induction, amplifying destructive inflammatory response and increasing loss of connective tissue and alveolar bone resorption. This method provides a valuable opportunity to assess the impact of periodontitis treatments.
Demonstrating the procedure will be Dr.Oscar Villa, PhD. Begin by sterilizing all surgical instruments before surgery. Prepare a mix of ketamine and xylazine by mixing 1.6 milliliters of ketamine with one milliliter of xylazine, diluted in PBS or saline, and store the stock at four degrees Celsius.
Dilute atipamezole to a final concentration of 0.25 milligrams per milliliter and buprenorphine to a final concentration of 0.03 milligrams per milliliter in PBS or saline, and store the stocks at four degrees Celsius. Prepare one milliliter of PG-LPS in sterile saline and store the stock at minus 20 degrees Celsius. Use female and male Wistar rats for the experiment.
Keep the animals housed in groups under the appropriate environment, with food and standard water offered ad libitum. After the rat is anesthetized, place the animal on its back on a heated surgical platform. Cover the animal's body during the procedure to prevent heat loss.
Administer 100%oxygen using a small nose cone, and monitor the pulse rate and oxygen saturation by pulse oximetry. Now, open the rat mouth using an aluminum mouth gag around the incisors. Retract the tongue with it and stabilize the maxilla and mandible in an open, comfortable working position, enabling access to mandibular molars.
Collect GCF using a total of four absorbent paper point number 30, by inserting it into the gingival crevice around the mesiopalatal of the M1 until slight resistance. Retain the paper point in the same position for 30 seconds before immediate removal. After collection, transfer the paper point immediately into a plastic vial and store at minus 80 degrees Celsius until assay performance.
Position the distal tail of the suture on the palatal side of the dentition and insert the proximal segment between the contact of M1 and second maxillary molars. Use the periosteal microsurgical elevator to insert the suture within the sulcus. Wrap the ligature around the buccal surface of the M1 very carefully, as the tissues at this level present a narrow zone of attached gingiva.
Ensure the suture is tightened on both ends to be driven into the gingival sulcus. Next, tie the ends of the suture with a surgeon's knot and trim the tails as short as possible. Insert the knot in the sulcus.
After ligature positioning, inject 40 microliters of PG-LPS in sterile saline into the subgingival tissue at the mesiopalatal side of the M1 bilaterally. To examine and adjust the ligature, place the anesthetized animal on its back and use a small nose cone during the procedure with 1%isoflurane and 100%oxygen for maintenance of the animal anesthesia. Open the wrap mouth using the aluminum mouth gag around the incisors, retracting the tongue with it and stabilizing the maxilla and mandible in an open, comfortable working position, enabling access to ligatures.
Tighten the ligatures against the gingiva with the help of a periosteal microsurgical elevator and make sure the suture of the ligatures is inserted, creating inflammation around the gingiva. After the ligature adjustment, bilaterally inject 40 microliters of PG-LPS into the subgingival tissue at the mesiopalatal side of the M1, as demonstrated earlier. After sacrificing the animal on the 14th day, collect GCF as shown earlier.
Transfer the paper point immediately into a plastic vial and store at minus 80 degrees Celsius until assay performance. The bi-dimensional images of the alveolar bone of maxillary molars show more bone volume in the basal control and higher alveolar bone loss after establishing periodontitis. Analysis of the sagittal images highlights a more significant alveolar bone loss in the interradicular bone area of the M1 and M2 after periodontitis establishment, compared to the basal control group.
After sacrifice, the palate presented differences in gingival recession in the M1 among different groups. The periodontitis group shows a more remarkable apical gingival migration and inflammation of the gingiva around the maxillary molars compared to the basal control group. Also, the periodontitis group showed a significantly higher release of pro-inflammatory cytokine 1L-1 beta from GCF than the control group.
Crucial steps in the procedure are the correct placement of the suture and knot in the sulcus, proper adjustment of the ligature, and accurate lipopolysaccharide injection during the 14-day protocol.
View the full transcript and gain access to thousands of scientific videos
Overview
This study presents a rat model of experimental periodontitis using lipopolysaccharide injections and ligature placement. This method effectively induces disease progression, allowing for the evaluation of treatments for periodontitis.
Key Study Components
Area of Science
- Neuroscience
- Dental Research
- Inflammation Biology
Background
- Periodontitis is a common inflammatory disease affecting the supporting structures of teeth.
- Understanding its progression is crucial for developing effective treatments.
- Animal models are essential for studying disease mechanisms and therapeutic interventions.
- This study utilizes a rat model to simulate periodontitis effectively.
Purpose of Study
- To establish a reliable rat model for studying periodontitis.
- To assess the impact of various treatments on disease progression.
- To evaluate the inflammatory response and tissue loss associated with periodontitis.
Methods Used
- Induction of periodontitis through ligature placement around maxillary molars.
- Repetitive injections of lipopolysaccharide derived from Porphyromonas gingivalis.
- Monitoring of alveolar bone loss and inflammation over a 14-day period.
- Use of anesthetic agents for surgical procedures.
Main Results
- Successful induction of periodontitis in the rat model.
- Significant alveolar bone loss observed.
- Increased inflammatory response noted in the affected tissues.
- This model provides a valuable platform for testing therapeutic interventions.
Conclusions
- The combined use of ligature and LPS injections is effective for inducing periodontitis.
- This model can facilitate further research into treatment options.
- Future studies can build on this methodology to explore disease mechanisms.
Frequently Asked Questions
Executive Industry Relevance
Robust preclinical models of periodontitis are essential for de-risking therapeutic hypotheses and validating targets in oral inflammation research. The combined ligature and lipopolysaccharide (LPS) rat model enables quantitative assessment of disease progression, supporting predictive confidence in early-stage drug discovery. This approach strengthens translational continuity by providing reproducible endpoints for evaluating candidate interventions and mechanistic studies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of inflammatory pathways and mediators relevant to periodontal disease.
- Supports functional validation of targets by quantifying IL-1β and bone loss as mechanistic readouts.
- Facilitates biological de-risking by modeling rapid disease induction and progression.
- Provides a platform for triaging candidate targets based on in vivo relevance.
Screening & Assay Development
- Establishes a validated in vivo system for downstream efficacy screening of anti-inflammatory compounds.
- Delivers standardized, reproducible endpoints such as gingival recession and CBCT-measured bone loss.
- Enables quantitative immunoassay outputs for cytokine profiling in gingival crevicular fluid.
- Supports assay readiness for comparative evaluation of multiple therapeutic modalities.
Translational & Preclinical Research
- Aligns preclinical endpoints with disease-relevant biomarkers such as IL-1β and bone resorption.
- Provides continuity from mechanistic discovery to preclinical validation of intervention strategies.
- Enables risk-adjusted advancement decisions based on quantitative disease progression metrics.
- Supports translational biomarker development for future clinical studies.
Pipeline & Workflow Integration
This rat model integrates into the discovery-to-preclinical continuum by enabling hypothesis testing, target validation, and quantitative assessment of intervention efficacy in periodontitis research.
- Discovery Biology: Supports mechanistic studies of inflammatory mediators and tissue destruction pathways.
- Screening: Provides reproducible, quantitative outputs for compound efficacy evaluation.
- Analytics: Delivers immunoassay and imaging-based measurements for robust statistical comparison.
- Translational Research: Aligns preclinical findings with disease-relevant biomarkers for clinical translation.
- Enterprise Reuse: Offers a standardized, scalable model for repeated use across therapeutic programs targeting oral inflammation.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Enhances standardization, reproducibility, and scalability of preclinical workflows.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by providing robust in vivo data.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of oral inflammation programs.
Implementation Considerations
- Requires expertise in small animal surgery and immunoassay techniques.
- Needs access to cone beam computed tomography (CBCT) and cytokine assay infrastructure.
- Demands rigorous cross-team standardization of ligature placement and LPS injection protocols.
- Adaptation may be needed for different rat strains or disease severities.
- Careful attention to procedural accuracy is critical for reproducibility and data integrity.
